Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
December 1, 2025
AI in Healthcare and Digital Health Today—December 1, 2025
November 30, 2025
Lucid Diligence Brief: Zetagen $12.9 million Series B1 in breast cancer
November 29, 2025
Lucid Diligence Brief: Imugene onCARlytics Carteyva collaboration
November 28, 2025
Respiratory Video Recap—November 28, 2025
November 28, 2025
Vaccines Video Recap—November 28, 2025
November 28, 2025
Public Health Today—28 November, 2025
November 28, 2025
Vaccines Today—November 28, 2025
November 28, 2025
Respiratory Today—November 28, 2025
November 28, 2025
Lucid Diligence Brief: Waker BioScience Series A in CGT
November 27, 2025
Cell and Gene Therapy Video Recap—November 27, 2025
November 27, 2025